Select Medical Holdings Corporation (NYSE:SEM) Receives $15.63 Consensus Price Target from Brokerages

Select Medical Holdings Corporation (NYSE:SEM) has earned an average recommendation of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $15.6250.

A number of equities research analysts have issued reports on SEM shares. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Finally, Zacks Research downgraded Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th.

Institutional Trading of Select Medical

A number of institutional investors have recently added to or reduced their stakes in SEM. Royal Bank of Canada increased its stake in shares of Select Medical by 8.5% during the 1st quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider’s stock worth $1,599,000 after purchasing an additional 7,502 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Select Medical by 96.6% during the 1st quarter. AQR Capital Management LLC now owns 33,894 shares of the health services provider’s stock valued at $566,000 after purchasing an additional 16,656 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Select Medical by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock valued at $1,075,000 after purchasing an additional 2,809 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Select Medical in the first quarter worth $220,000. Finally, Goldman Sachs Group Inc. increased its position in Select Medical by 25.3% during the first quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider’s stock worth $12,169,000 after buying an additional 147,183 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Trading Down 0.0%

Shares of NYSE SEM opened at $16.35 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.89. Select Medical has a one year low of $11.65 and a one year high of $18.60. The business has a 50-day moving average price of $15.85 and a two-hundred day moving average price of $14.78. The firm has a market capitalization of $2.03 billion, a PE ratio of 14.21, a PEG ratio of 0.94 and a beta of 1.12.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The company had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Select Medical had a return on equity of 7.26% and a net margin of 2.68%.Select Medical’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $0.18 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts predict that Select Medical will post 1.17 earnings per share for the current fiscal year.

Select Medical announced that its Board of Directors has approved a stock buyback plan on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to buy up to 49.5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 12th. Investors of record on Monday, March 2nd were paid a $0.0625 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s payout ratio is presently 21.74%.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.